Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119) Article

Berk, Lawrence, Berkey, Brian, Rich, Tyvin et al. (2007). Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119) . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 68(3), 852-857. 10.1016/j.ijrobp.2007.01.012

Open Access

cited authors

  • Berk, Lawrence; Berkey, Brian; Rich, Tyvin; Hrushesky, William; Blask, David; Gallagher, Michael; Kudrimoti, Mahesh; McGarry, Ronald C; Suh, John; Mehta, Minesh

sustainable development goals

authors

publication date

  • July 1, 2007

webpage

published in

keywords

  • CANCER-PATIENTS
  • CHEMOTHERAPY
  • COLORECTAL-CANCER
  • ETOPOSIDE
  • INTERLEUKIN-2 PLUS MELATONIN
  • Life Sciences & Biomedicine
  • MENTAL-STATE-EXAMINATION
  • NEUROHORMONE MELATONIN
  • NEUROIMMUNOTHERAPY
  • Oncology
  • PINEAL HORMONE MELATONIN
  • Radiology, Nuclear Medicine & Medical Imaging
  • SUPPORTIVE CARE
  • Science & Technology
  • brain metastases
  • chronobiology
  • melatonin
  • randomized trial
  • survival

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 852

end page

  • 857

volume

  • 68

issue

  • 3